©istockphoto/kwanchaichaiudom New research funded by the National Institute on Drug Abuse (NIDA) revealed that the initial relapse rates among opioid-dependent adults in the criminal justice system was lower for participants receiving extended-release naltrexone than for those receiving treatment...
©Shutterstock/David Smart More than 30 percent of Americans have some form of chronic pain. Yet, the over-reliance on the millions of opioid pain reliever prescriptions dispensed yearly have resulted in a national epidemic of overdose deaths and addiction. A review article published today in The...
©istockphoto/wenht NIDA-funded research using brain scans shows that severe marijuana dependence (now referred to as cannabis use disorder) is associated with a reduced release of dopamine within the striatum, a region involved in working memory, impulsivity and attention. Lower dopamine release...
©iStock/AlexRaths New research funded by the National Institute on Drug Abuse revealed that of previously incarcerated youths, more than 90% of males and nearly 80% of females had a substance use disorder at some point in their lifetime. The longitudinal study randomly sampled 1,829 youth -- ages...
An online guide about interventions in early childhood that can help prevent drug use and other unhealthy behaviors was launched today by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The guide offers research-based principles that affect a child’s self-...
What: NIH to host Marijuana and Cannabinoids: A Neuroscience Research Summit, focusing on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system will be discussed...
The National Institute on Drug Abuse (NIDA), in partnership with the Appalachian Regional Commission (ARC), has announced a NIDA funding opportunity for one-year, services planning research grants to address a dramatic increase in adverse outcomes associated with increased opioid injection drug...
A new scientific analysis shows prescriptions for naloxone, a medication designed to rapidly reverse opioid overdose, has increased ten-fold in the past eighteen months. Naloxone is traditionally distributed through community programs. To help address the recent dramatic numbers of overdose...
This week the National Institute on Drug Abuse (NIDA) announced that Dr. Marilyn Huestis, Chief of Chemistry and Drug Metabolism at NIDA’s Intramural Research Program (IRP) in Baltimore, Maryland, has retired from government service. Dr. Huestis is internationally known and respected for her work...
The National Institute on Drug Abuse (NIDA) has released its Strategic Plan for 2016-2020: Advancing Addiction Science, focusing on its mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. Drug...